BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22445595)

  • 1. Association between clinical outcome and antiarrhythmic treatment in heart failure patients who have atrial fibrillation upon admission to the hospital.
    Watanabe E; Arakawa T; Okuda K; Yamamoto M; Ichikawa T; Harigaya H; Sobue Y; Ozaki Y
    J Cardiol; 2012 Jul; 60(1):31-5. PubMed ID: 22445595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K
    Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function.
    Hemels ME; Wiesfeld AC; Van Veldhuisen DJ; Van den Berg MP; Van Gelder IC
    Europace; 2007 Apr; 9(4):239-45. PubMed ID: 17332026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.
    Mountantonakis SE; Grau-Sepulveda MV; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):191-201. PubMed ID: 22361078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure.
    Taillandier S; Brunet Bernard A; Lallemand B; Simeon E; Pericart L; Clementy N; Babuty D; Fauchier L
    Am J Cardiol; 2014 Apr; 113(7):1189-95. PubMed ID: 24507167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
    Kawabata M; Hirao K; Hachiya H; Higuchi K; Tanaka Y; Yagishita A; Inaba O; Isobe M
    J Cardiol; 2011 Sep; 58(2):108-15. PubMed ID: 21831597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication.
    Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP
    Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
    Mulder BA; van Veldhuisen DJ; Crijns HJ; Böhm M; Cohen-Solal A; Babalis D; Roughton M; Flather MD; Coats AJ; Van Gelder IC
    Eur J Heart Fail; 2012 Oct; 14(10):1171-8. PubMed ID: 22764183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations.
    Conti A; Canuti E; Mariannini Y; Viviani G; Poggioni C; Boni V; Pini R; Vanni S; Padeletti L; Gensini GF
    Am J Emerg Med; 2012 Nov; 30(9):1962-9. PubMed ID: 22795994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study.
    Fung JW; Sanderson JE; Yip GW; Zhang Q; Yu CM
    J Card Fail; 2007 Oct; 13(8):649-55. PubMed ID: 17923357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.